Study, to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella
Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
† Indicates status has not been verified in more than two years